Session 8: Hormone Considerations in Transgender Patients with Gynecologic Cancer


Panelists:
Allison Asante, PA-C, MBA
Ishani, Choksi, MD
Minghao Liu, MD
Bobbie J. Rimel, MD (moderator)
 

Recorded on July 18, 2022.

This session is eligible for 1.0 CE credits.

Target Audience

HealthCare Providers, Physicians, Trainees, APPs, Fellows, Residents, Pharmacists, Nurses, Office Staff

Learning Objectives

  • Review the general standards of what’s “normal” in cross-gender hormone therapy patients with an endocrinologist
  • Explore risks and benefits of cross-gender hormones to consider if a transgender patient elects to use them
  • Discuss how to counsel a patient about hormone therapy before and during cancer treatment with a gynecologic oncologist

Additional Information

AttachmentSize
PDF icon SGO 7.25.22 Mod 8 Enduring-LN.pdf151.37 KB
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this Enduring material for a maximum of 1.00 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 AMA PRA Category 1 Credits™- For Non-physicians
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    PAs may claim a maximum of 1.00 Enduring Category 1 credits for completing this activity.
  • 1.00 CNE Contact Hours
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this activity for a maximum of 1.00 Enduring ANCC contact hours.
  • 1.00 Participation
Course opens: 
07/22/2022
Course expires: 
07/25/2023
Cost:
$0.00
Part of: 
Welcoming Spaces: Treating Your LGBTQ+ Patients
Rating: 
0

Society of Gynecologic Oncology 
2022 Welcoming Spaces - Module 8 - Hormone Considerations in Transgender Patients with Gynecologic Cancer
Enduring: July 25, 2022 – July 25, 2023
Online

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO).  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation
Amedco LLC designates this enduring material for a maximum of 1.0  AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 Enduring ANCC contact hours.

Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 Enduring knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this Enduring material for a maximum of 1.00 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 AMA PRA Category 1 Credits™- For Non-physicians
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    PAs may claim a maximum of 1.00 Enduring Category 1 credits for completing this activity.
  • 1.00 CNE Contact Hours
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this activity for a maximum of 1.00 Enduring ANCC contact hours.
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.